Melatonin, energy metabolism, and obesity: a review - PubMed (original) (raw)
Review
doi: 10.1111/jpi.12137. Epub 2014 Apr 5.
Affiliations
- PMID: 24654916
- DOI: 10.1111/jpi.12137
Review
Melatonin, energy metabolism, and obesity: a review
J Cipolla-Neto et al. J Pineal Res. 2014 May.
Abstract
Melatonin is an old and ubiquitous molecule in nature showing multiple mechanisms of action and functions in practically every living organism. In mammals, pineal melatonin functions as a hormone and a chronobiotic, playing a major role in the regulation of the circadian temporal internal order. The anti-obesogen and the weight-reducing effects of melatonin depend on several mechanisms and actions. Experimental evidence demonstrates that melatonin is necessary for the proper synthesis, secretion, and action of insulin. Melatonin acts by regulating GLUT4 expression and/or triggering, via its G-protein-coupled membrane receptors, the phosphorylation of the insulin receptor and its intracellular substrates mobilizing the insulin-signaling pathway. Melatonin is a powerful chronobiotic being responsible, in part, by the daily distribution of metabolic processes so that the activity/feeding phase of the day is associated with high insulin sensitivity, and the rest/fasting is synchronized to the insulin-resistant metabolic phase of the day. Furthermore, melatonin is responsible for the establishment of an adequate energy balance mainly by regulating energy flow to and from the stores and directly regulating the energy expenditure through the activation of brown adipose tissue and participating in the browning process of white adipose tissue. The reduction in melatonin production, as during aging, shift-work or illuminated environments during the night, induces insulin resistance, glucose intolerance, sleep disturbance, and metabolic circadian disorganization characterizing a state of chronodisruption leading to obesity. The available evidence supports the suggestion that melatonin replacement therapy might contribute to restore a more healthy state of the organism.
Keywords: circadian rhythm; energy metabolism; insulin; melatonin; obesity; review.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
- Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity.
Tan DX, Manchester LC, Fuentes-Broto L, Paredes SD, Reiter RJ. Tan DX, et al. Obes Rev. 2011 Mar;12(3):167-88. doi: 10.1111/j.1467-789X.2010.00756.x. Obes Rev. 2011. PMID: 20557470 Review. - Melatonin improves insulin sensitivity independently of weight loss in old obese rats.
Zanuto R, Siqueira-Filho MA, Caperuto LC, Bacurau RF, Hirata E, Peliciari-Garcia RA, do Amaral FG, Marçal AC, Ribeiro LM, Camporez JP, Carpinelli AR, Bordin S, Cipolla-Neto J, Carvalho CR. Zanuto R, et al. J Pineal Res. 2013 Sep;55(2):156-65. doi: 10.1111/jpi.12056. Epub 2013 Apr 9. J Pineal Res. 2013. PMID: 23565768 - Inter-relationships of the chronobiotic, melatonin, with leptin and adiponectin: implications for obesity.
Szewczyk-Golec K, Woźniak A, Reiter RJ. Szewczyk-Golec K, et al. J Pineal Res. 2015 Oct;59(3):277-91. doi: 10.1111/jpi.12257. Epub 2015 Jul 14. J Pineal Res. 2015. PMID: 26103557 Review. - "Browning" of adipose tissue--regulation and therapeutic perspectives.
Peschechera A, Eckel J. Peschechera A, et al. Arch Physiol Biochem. 2013 Oct;119(4):151-60. doi: 10.3109/13813455.2013.796995. Epub 2013 May 30. Arch Physiol Biochem. 2013. PMID: 23721302 Review. - Chronomedicine and type 2 diabetes: shining some light on melatonin.
Forrestel AC, Miedlich SU, Yurcheshen M, Wittlin SD, Sellix MT. Forrestel AC, et al. Diabetologia. 2017 May;60(5):808-822. doi: 10.1007/s00125-016-4175-1. Epub 2016 Dec 16. Diabetologia. 2017. PMID: 27981356 Review.
Cited by
- Neurogenetic basis for circadian regulation of metabolism by the hypothalamus.
Cedernaes J, Waldeck N, Bass J. Cedernaes J, et al. Genes Dev. 2019 Sep 1;33(17-18):1136-1158. doi: 10.1101/gad.328633.119. Genes Dev. 2019. PMID: 31481537 Free PMC article. Review. - Promising Antineoplastic Actions of Melatonin.
Favero G, Moretti E, Bonomini F, Reiter RJ, Rodella LF, Rezzani R. Favero G, et al. Front Pharmacol. 2018 Oct 16;9:1086. doi: 10.3389/fphar.2018.01086. eCollection 2018. Front Pharmacol. 2018. PMID: 30386235 Free PMC article. Review. - Kidney Damage Caused by Obesity and Its Feasible Treatment Drugs.
Wang M, Wang Z, Chen Y, Dong Y. Wang M, et al. Int J Mol Sci. 2022 Jan 11;23(2):747. doi: 10.3390/ijms23020747. Int J Mol Sci. 2022. PMID: 35054932 Free PMC article. Review. - Melatonin treatment suppresses appetite genes and improves adipose tissue plasticity in diet-induced obese zebrafish.
Montalbano G, Mania M, Abbate F, Navarra M, Guerrera MC, Laura R, Vega JA, Levanti M, Germanà A. Montalbano G, et al. Endocrine. 2018 Nov;62(2):381-393. doi: 10.1007/s12020-018-1653-x. Epub 2018 Jun 20. Endocrine. 2018. PMID: 29926348 - Melatonin: A Molecule for Reducing Breast Cancer Risk.
González-González A, Mediavilla MD, Sánchez-Barceló EJ. González-González A, et al. Molecules. 2018 Feb 6;23(2):336. doi: 10.3390/molecules23020336. Molecules. 2018. PMID: 29415446 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical